Venlafaxine Hydrochloride
Pricing Report NDC 68025-080-30

Current NADAC: $0.26124 per EA · Effective May 20, 2026 · Est. package price $7.84 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The current wholesale acquisition cost for Venlafaxine Hydrochloride (NDC 68025-080-30) is $0.26124 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2026.

As a provided by Vertical Pharmaceuticals, Llc, this medication is distributed in a 30 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.26124
Per EA

Effective Date
May 20, 2026
Billable Units
30 EA
Estimated Package Price
$7.84
Data Status
As of May 27, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.19370 to $5.43538 per EA. Over this 9 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1937 - $5.4354
Market Volatility
2,706.08% Variance
Latest Trend
1.33%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 20, 2026 $0.26124 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $0.26476 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $0.28484 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $0.33390 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $0.39800 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $0.51829 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $0.63424 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $0.73623 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $0.80712 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $0.80076 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $0.82748 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $0.74627 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026